Media Coverage

The Plant Pathology Journal: Bactericidal Efficacy of Oxidized Silver

August 9, 2022

Bactericidal Efficacy Oxidized Silver

StarFish Medical Bio Services manager, Nick Allan, is a co-author of an original research article, Bactericidal Efficacy of Oxidized Silver against Biofilms Formed by Curtobacterium flaccumfaciens pv. flaccumfaciens, published in the August 1, 2022 online edition of The Plant Pathology Journal.

Bacterial wilt is a re-emerging disease on dry bean and can affect many other crop species within the Fabaceae. The causal agent, Curtobacterium flaccumfaciens pv. flaccumfaciens (CFF), is a small, Gram-positive, rod-shaped bacterium that is seed-transmitted. Infections in the host become systemic, leading to wilting and economic loss. This study characterizes the efficacies of five bactericidal chemicals against CFF. It was hypothesized that this bacterium was capable of forming biofilms, and that the cells within biofilms would be more tolerant to bactericidal treatments.

Read the article here.

 

About The Plant Pathology Journal

The Plant Pathology Journal (Plant Pathol. J.) is a peer-reviewed journal that publishes scientific results of plant pathology research as original articles, research notes and review papers submitted from scientists around the world. The journal scope includes epidemiology, diagnosis and management of disease, modeling with forecasting, biochemistry and physiology of disease, as well as plant-microbe interactions. Note that manuscripts focused on the first report of a new disease are not included in the scope of the journal.

Editorial Staff

Youn-Sig Kwak
Editor-in-Chief
paper@kspp.org

 

About StarFish Medical

StarFish Medical provides award-winning design, development, commercialization, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Digital Health, Cardiovascular, Neurology, Urology, Gastroenterology, Otology, Ophthalmology, and In-Vitro Diagnostics.

StarFish Medical’s technical expertise includes electronics, mechanical, software/firmware systems engineering, in addition to industrial design and human factors. Regulatory Affairs (RA) and Quality Assurance (QA) consultants at StarFish Medical provide regulatory assistance for FDA, CE Mark and Health Canada submissions. Services include QA support for setting up QMS for start-up companies with implementation at the client’s site, and assisting with ISO 13485 certification audits.

For media inquiries:

Mike Camplin, VP, Marketing, StarFish Medical,  250.388.3537 x210  mcamplin@starfishmedical.com

Related Link: www.starfishmedical.com

 

« All News

Join over 6000 medical device professionals who receive our engineering, regulatory and commercialization insights and tips every month.

Website Survey

Please answer a few questions about our website.

Take Survey No Thanks